Compounds > dextrothyroxine
Page last updated: 2024-08-20

dextrothyroxine and AIDS Seroconversion

dextrothyroxine has been researched along with AIDS Seroconversion in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Bailey, AC; Cooke, GS; Dosekun, O; Hatcher, J; Pintilie, H; Ross, SA1
Anderson, L; Anderson, M; Chadban, S; Davis, R; Gracey, D; Lai, C; Wyburn, K1
Burns, P; Strote, J; Yang, S1
Caumes, E; Cracco, C; Danis, M; Mattioni, S; Thellier, M; Valin, N1
Aquilina, C; Sire, S; Viraben, R1
Aquino, V; Bakos, L; Bakos, RM; D'Elia, P; Reusch, MC1
Buttner, DW; Fischer, P; Kabwa, P; Kipp, W1
Stanley, B1

Reviews

1 review(s) available for dextrothyroxine and AIDS Seroconversion

ArticleYear
Ivermectin-responsive Demodex infestation during human immunodeficiency virus infection. A case report and literature review.
    Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:4

    Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Diagnosis, Differential; Drug Administration Schedule; Follow-Up Studies; HIV Seropositivity; Humans; Ivermectin; Male; Middle Aged; Mite Infestations; Risk Assessment; Rosacea; Treatment Outcome

2002

Other Studies

7 other study(ies) available for dextrothyroxine and AIDS Seroconversion

ArticleYear
    International journal of STD & AIDS, 2020, Volume: 31, Issue:5

    Topics: Adult; Aged; Albendazole; Animals; Feces; HIV Seropositivity; Homosexuality, Male; Humans; Ivermectin; Male; Middle Aged; Risk-Taking; Strongyloides stercoralis; Strongyloidiasis; Treatment Outcome

2020
Strongyloides hyperinfection in an HIV-positive kidney transplant recipient: a case report.
    BMC infectious diseases, 2020, Aug-18, Volume: 20, Issue:1

    Topics: Animals; Antiparasitic Agents; Black or African American; HIV; HIV Seropositivity; Humans; Ivermectin; Kidney Transplantation; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis; Tissue Donors; Transplant Recipients; Treatment Outcome

2020
Norwegian Scabies.
    The western journal of emergency medicine, 2015, Volume: 16, Issue:4

    Topics: Administration, Cutaneous; Antiparasitic Agents; HIV Seropositivity; Humans; Insecticides; Ivermectin; Male; Middle Aged; Permethrin; Scabies; Skin

2015
Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment.
    Annals of tropical medicine and parasitology, 2008, Volume: 102, Issue:8

    Topics: Animals; Antinematodal Agents; Fatal Outcome; HIV Seropositivity; Humans; Immunocompromised Host; Ivermectin; Lung Diseases, Parasitic; Male; Middle Aged; Recurrence; Strongyloides stercoralis; Strongyloidiasis; Tuberculosis

2008
Crusted scabies of the vulva.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:5

    Topics: Adult; Animals; Diagnosis, Differential; Female; HIV Seropositivity; Humans; Immunocompromised Host; Insecticides; Ivermectin; Scabies; Vulva

2007
Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
    The American journal of tropical medicine and hygiene, 1995, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Animals; Blotting, Western; CD4 Lymphocyte Count; CD4-CD8 Ratio; Drug Tolerance; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Skin; Uganda

1995
Oral sex and the transmission of non-viral STIs.
    Sexually transmitted infections, 1999, Volume: 75, Issue:1

    Topics: Aged; Antinematodal Agents; HIV Seropositivity; Homosexuality, Male; Humans; Ivermectin; Male; Sexual Behavior; Strongyloidiasis

1999